Article Details
Retrieved on: 2024-04-29 18:07:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® ...
Article found on: www.investorsobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here